Clinical Research Directory
Browse clinical research sites, groups, and studies.
Back to Studies
RECRUITING
NCT06003348
PHASE4
Hydroxycitrate: A Novel Therapy for Calcium Phosphate Urinary Stones
Sponsor: University of Texas Southwestern Medical Center
View on ClinicalTrials.gov
Summary
This study tests whether hydroxycitrate, a molecule closely related to citrate, can reduce calcium phosphate stone recurrence.
Key Details
Gender
All
Age Range
21 Years - 99 Years
Study Type
INTERVENTIONAL
Enrollment
25
Start Date
2023-12-13
Completion Date
2028-08-31
Last Updated
2025-04-06
Healthy Volunteers
No
Conditions
Interventions
DIETARY_SUPPLEMENT
OHCit- standard dose
Hydroxycitrate Over-the-counter supplement, not FDA approved or regulated.
DRUG
Potassium Citrate
10 mEq Extended-release tablets for oral use
DRUG
Placebo
Placebo
DIETARY_SUPPLEMENT
OHCit- low dose
Hydroxycitrate Over-the-counter supplement, not FDA approved or regulated.
Locations (1)
UT Southwestern Medical Center
Dallas, Texas, United States